China’s WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to US drug maker Merck & Co for about US$500 million, ahead of potential US legislation that would restrict ...
the Hang Seng China Enterprise ETF, Wuxi Biologics, Tencent, China National Petroleum, and Semiconductor Manufacturing International (SMIC). Shanghai, Shenzhen, and the STAR Board diverged to ...
WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...
WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...
Hosted on MSN1mon
WuXi AppTec Offloads Gene Therapy Unit Amid Rising US RestrictionsWuXi AppTec, a prominent Chinese company listed ... pharmaceutical and biotech industries to reduce dependency on China for critical operations, including drug manufacturing and early-stage ...
Jan 6 (Reuters) - China's WuXi Biologics (2269.HK), opens new tab said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co (MRK.N), opens new tab for about $500 ...
China's WuXi Biologics has confirmed it will sell its vaccine facility in Ireland to US drugmaker Merck & Co for about €500 million. The WuXi Biologics facility is located in Dundalk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback